カテゴリー： QYResearch, 世界

世界のライノウイルス感染薬市場 2019年

【英語タイトル】Global Rhinovirus Infections Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X14407）・商品コード：DATA909X14407
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、ライノウイルス感染薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他に、用途別には、クリニック、病院、その他にセグメント区分し、ライノウイルス感染薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・ライノウイルス感染薬の世界市場概要
・ライノウイルス感染薬の製造コスト構成分析
・ライノウイルス感染薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・ライノウイルス感染薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・ライノウイルス感染薬のセグメント分析（種類別）
（塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他）
・ライノウイルス感染薬のセグメント分析（用途別）
（クリニック、病院、その他）
・ライノウイルス感染薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（AIMM Therapeutics B.V.、Biological Mimetics, Inc.、Biota Pharmaceuticals, Inc.、Boehringer Ingelheim GmbH、Johnson & Johnson、Novartis AG、Theraclone Sciences, Inc.、）
・ライノウイルス感染薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Rhinovirus Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Rhinovirus Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rhinovirus Infections Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Rhinovirus Infections Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Rhinovirus Infections Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AIMM Therapeutics B.V.
Biological Mimetics, Inc.
Biota Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
Johnson & Johnson
Novartis AG
Theraclone Sciences, Inc.
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Cetylpyridinium Chloride
Human Rhinovirus (polyvalent) Vaccine
KR-22809
Others

Segment by Application
Clinic
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Rhinovirus Infections Drug
1.1 Definition of Rhinovirus Infections Drug
1.2 Rhinovirus Infections Drug Segment by Type
1.2.1 Global Rhinovirus Infections Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Cetylpyridinium Chloride
1.2.3 Human Rhinovirus (polyvalent) Vaccine
1.2.4 KR-22809
1.2.5 Others
1.3 Rhinovirus Infections Drug Segment by Applications
1.3.1 Global Rhinovirus Infections Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Rhinovirus Infections Drug Overall Market
1.4.1 Global Rhinovirus Infections Drug Revenue (2014-2025)
1.4.2 Global Rhinovirus Infections Drug Production (2014-2025)
1.4.3 North America Rhinovirus Infections Drug Status and Prospect (2014-2025)
1.4.4 Europe Rhinovirus Infections Drug Status and Prospect (2014-2025)
1.4.5 China Rhinovirus Infections Drug Status and Prospect (2014-2025)
1.4.6 Japan Rhinovirus Infections Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Rhinovirus Infections Drug Status and Prospect (2014-2025)
1.4.8 India Rhinovirus Infections Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Rhinovirus Infections Drug
2.3 Manufacturing Process Analysis of Rhinovirus Infections Drug
2.4 Industry Chain Structure of Rhinovirus Infections Drug

3 Development and Manufacturing Plants Analysis of Rhinovirus Infections Drug
3.1 Capacity and Commercial Production Date
3.2 Global Rhinovirus Infections Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Rhinovirus Infections Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Rhinovirus Infections Drug Production and Capacity Analysis
4.2 Rhinovirus Infections Drug Revenue Analysis
4.3 Rhinovirus Infections Drug Price Analysis
4.4 Market Concentration Degree

5 Rhinovirus Infections Drug Regional Market Analysis
5.1 Rhinovirus Infections Drug Production by Regions
5.1.1 Global Rhinovirus Infections Drug Production by Regions
5.1.2 Global Rhinovirus Infections Drug Revenue by Regions
5.2 Rhinovirus Infections Drug Consumption by Regions
5.3 North America Rhinovirus Infections Drug Market Analysis
5.3.1 North America Rhinovirus Infections Drug Production
5.3.2 North America Rhinovirus Infections Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Rhinovirus Infections Drug Import and Export
5.4 Europe Rhinovirus Infections Drug Market Analysis
5.4.1 Europe Rhinovirus Infections Drug Production
5.4.2 Europe Rhinovirus Infections Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Rhinovirus Infections Drug Import and Export
5.5 China Rhinovirus Infections Drug Market Analysis
5.5.1 China Rhinovirus Infections Drug Production
5.5.2 China Rhinovirus Infections Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Rhinovirus Infections Drug Import and Export
5.6 Japan Rhinovirus Infections Drug Market Analysis
5.6.1 Japan Rhinovirus Infections Drug Production
5.6.2 Japan Rhinovirus Infections Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Rhinovirus Infections Drug Import and Export
5.7 Southeast Asia Rhinovirus Infections Drug Market Analysis
5.7.1 Southeast Asia Rhinovirus Infections Drug Production
5.7.2 Southeast Asia Rhinovirus Infections Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Rhinovirus Infections Drug Import and Export
5.8 India Rhinovirus Infections Drug Market Analysis
5.8.1 India Rhinovirus Infections Drug Production
5.8.2 India Rhinovirus Infections Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Rhinovirus Infections Drug Import and Export

6 Rhinovirus Infections Drug Segment Market Analysis (by Type)
6.1 Global Rhinovirus Infections Drug Production by Type
6.2 Global Rhinovirus Infections Drug Revenue by Type
6.3 Rhinovirus Infections Drug Price by Type

7 Rhinovirus Infections Drug Segment Market Analysis (by Application)
7.1 Global Rhinovirus Infections Drug Consumption by Application
7.2 Global Rhinovirus Infections Drug Consumption Market Share by Application (2014-2019)

8 Rhinovirus Infections Drug Major Manufacturers Analysis
8.1 AIMM Therapeutics B.V.
8.1.1 AIMM Therapeutics B.V. Rhinovirus Infections Drug Production Sites and Area Served
8.1.2 AIMM Therapeutics B.V. Product Introduction, Application and Specification
8.1.3 AIMM Therapeutics B.V. Rhinovirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Biological Mimetics, Inc.
8.2.1 Biological Mimetics, Inc. Rhinovirus Infections Drug Production Sites and Area Served
8.2.2 Biological Mimetics, Inc. Product Introduction, Application and Specification
8.2.3 Biological Mimetics, Inc. Rhinovirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Biota Pharmaceuticals, Inc.
8.3.1 Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Production Sites and Area Served
8.3.2 Biota Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.3.3 Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Boehringer Ingelheim GmbH
8.4.1 Boehringer Ingelheim GmbH Rhinovirus Infections Drug Production Sites and Area Served
8.4.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification
8.4.3 Boehringer Ingelheim GmbH Rhinovirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson Rhinovirus Infections Drug Production Sites and Area Served
8.5.2 Johnson & Johnson Product Introduction, Application and Specification
8.5.3 Johnson & Johnson Rhinovirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Novartis AG
8.6.1 Novartis AG Rhinovirus Infections Drug Production Sites and Area Served
8.6.2 Novartis AG Product Introduction, Application and Specification
8.6.3 Novartis AG Rhinovirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Theraclone Sciences, Inc.
8.7.1 Theraclone Sciences, Inc. Rhinovirus Infections Drug Production Sites and Area Served
8.7.2 Theraclone Sciences, Inc. Product Introduction, Application and Specification
8.7.3 Theraclone Sciences, Inc. Rhinovirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served

9 Development Trend of Analysis of Rhinovirus Infections Drug Market
9.1 Global Rhinovirus Infections Drug Market Trend Analysis
9.1.1 Global Rhinovirus Infections Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Rhinovirus Infections Drug Regional Market Trend
9.2.1 North America Rhinovirus Infections Drug Forecast 2019-2025
9.2.2 Europe Rhinovirus Infections Drug Forecast 2019-2025
9.2.3 China Rhinovirus Infections Drug Forecast 2019-2025
9.2.4 Japan Rhinovirus Infections Drug Forecast 2019-2025
9.2.5 Southeast Asia Rhinovirus Infections Drug Forecast 2019-2025
9.2.6 India Rhinovirus Infections Drug Forecast 2019-2025
9.3 Rhinovirus Infections Drug Market Trend (Product Type)
9.4 Rhinovirus Infections Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Rhinovirus Infections Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Rhinovirus Infections Drug
Table Global Rhinovirus Infections Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Rhinovirus Infections Drug Production Market Share by Types in 2018
Figure Cetylpyridinium Chloride Product Picture
Figure Human Rhinovirus (polyvalent) Vaccine Product Picture
Figure KR-22809 Product Picture
Figure Others Product Picture
Table Global Rhinovirus Infections Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Rhinovirus Infections Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Rhinovirus Infections Drug Revenue (Million USD) (2014-2025)
Figure Global Rhinovirus Infections Drug Production (K Pcs) (2014-2025)
Figure North America Rhinovirus Infections Drug Market Size (Million USD) (2014-2025)
Figure Europe Rhinovirus Infections Drug Market Size (Million USD) (2014-2025)
Figure China Rhinovirus Infections Drug Market Size (Million USD) (2014-2025)
Figure Japan Rhinovirus Infections Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Rhinovirus Infections Drug Market Size (Million USD) (2014-2025)
Figure India Rhinovirus Infections Drug Market Size (Million USD) (2014-2025)
Table Rhinovirus Infections Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Rhinovirus Infections Drug in 2018
Figure Manufacturing Process Analysis of Rhinovirus Infections Drug
Figure Industry Chain Structure of Rhinovirus Infections Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Rhinovirus Infections Drug Manufacturing Plants Distribution
Table Rhinovirus Infections Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Rhinovirus Infections Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Rhinovirus Infections Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Rhinovirus Infections Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Rhinovirus Infections Drug Production Share by Manufacturers in 2018
Table Rhinovirus Infections Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Rhinovirus Infections Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Rhinovirus Infections Drug Revenue Share by Manufacturers in 2018
Table Rhinovirus Infections Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Rhinovirus Infections Drug Production by Regions 2014-2019 (K Pcs)
Table Global Rhinovirus Infections Drug Production Market Share by Regions 2014-2019
Figure Global Rhinovirus Infections Drug Production Market Share by Regions in 2018
Table Global Rhinovirus Infections Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Rhinovirus Infections Drug Revenue Market Share by Regions 2014-2019
Figure Global Rhinovirus Infections Drug Revenue Market Share by Regions in 2018
Table Global Rhinovirus Infections Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Rhinovirus Infections Drug Consumption Market Share by Regions 2014-2019
Figure North America Rhinovirus Infections Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Rhinovirus Infections Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Rhinovirus Infections Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Rhinovirus Infections Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Rhinovirus Infections Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Rhinovirus Infections Drug Production, Consumption Import and Export (K Pcs)
Figure China Rhinovirus Infections Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Rhinovirus Infections Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Rhinovirus Infections Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Rhinovirus Infections Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Rhinovirus Infections Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Rhinovirus Infections Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Rhinovirus Infections Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Rhinovirus Infections Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Rhinovirus Infections Drug Production, Consumption Import and Export (K Pcs)
Figure India Rhinovirus Infections Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Rhinovirus Infections Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Rhinovirus Infections Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Rhinovirus Infections Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Rhinovirus Infections Drug Market Share by Application (2014-2019)
Table AIMM Therapeutics B.V. Rhinovirus Infections Drug Production Sites and Area Served
Table AIMM Therapeutics B.V. Rhinovirus Infections Drug Product Introduction, Application and Specification
Table AIMM Therapeutics B.V. Rhinovirus Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AIMM Therapeutics B.V. Rhinovirus Infections Drug Production Growth Rate (2014-2019)
Table AIMM Therapeutics B.V. Rhinovirus Infections Drug Production Market Share (2014-2019)
Figure AIMM Therapeutics B.V. Rhinovirus Infections Drug Revenue Market Share (2014-2019)
Table AIMM Therapeutics B.V. Rhinovirus Infections Drug Main Business and Markets Served
Table Biological Mimetics, Inc. Rhinovirus Infections Drug Production Sites and Area Served
Table Biological Mimetics, Inc. Rhinovirus Infections Drug Product Introduction, Application and Specification
Table Biological Mimetics, Inc. Rhinovirus Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biological Mimetics, Inc. Rhinovirus Infections Drug Production Growth Rate (2014-2019)
Table Biological Mimetics, Inc. Rhinovirus Infections Drug Production Market Share (2014-2019)
Figure Biological Mimetics, Inc. Rhinovirus Infections Drug Revenue Market Share (2014-2019)
Table Biological Mimetics, Inc. Rhinovirus Infections Drug Main Business and Markets Served
Table Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Production Sites and Area Served
Table Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Product Introduction, Application and Specification
Table Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Production Growth Rate (2014-2019)
Table Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Production Market Share (2014-2019)
Figure Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Revenue Market Share (2014-2019)
Table Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Main Business and Markets Served
Table Boehringer Ingelheim GmbH Rhinovirus Infections Drug Production Sites and Area Served
Table Boehringer Ingelheim GmbH Rhinovirus Infections Drug Product Introduction, Application and Specification
Table Boehringer Ingelheim GmbH Rhinovirus Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Boehringer Ingelheim GmbH Rhinovirus Infections Drug Production Growth Rate (2014-2019)
Table Boehringer Ingelheim GmbH Rhinovirus Infections Drug Production Market Share (2014-2019)
Figure Boehringer Ingelheim GmbH Rhinovirus Infections Drug Revenue Market Share (2014-2019)
Table Boehringer Ingelheim GmbH Rhinovirus Infections Drug Main Business and Markets Served
Table Johnson & Johnson Rhinovirus Infections Drug Production Sites and Area Served
Table Johnson & Johnson Rhinovirus Infections Drug Product Introduction, Application and Specification
Table Johnson & Johnson Rhinovirus Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson Rhinovirus Infections Drug Production Growth Rate (2014-2019)
Table Johnson & Johnson Rhinovirus Infections Drug Production Market Share (2014-2019)
Figure Johnson & Johnson Rhinovirus Infections Drug Revenue Market Share (2014-2019)
Table Johnson & Johnson Rhinovirus Infections Drug Main Business and Markets Served
Table Novartis AG Rhinovirus Infections Drug Production Sites and Area Served
Table Novartis AG Rhinovirus Infections Drug Product Introduction, Application and Specification
Table Novartis AG Rhinovirus Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Rhinovirus Infections Drug Production Growth Rate (2014-2019)
Table Novartis AG Rhinovirus Infections Drug Production Market Share (2014-2019)
Figure Novartis AG Rhinovirus Infections Drug Revenue Market Share (2014-2019)
Table Novartis AG Rhinovirus Infections Drug Main Business and Markets Served
Table Theraclone Sciences, Inc. Rhinovirus Infections Drug Production Sites and Area Served
Table Theraclone Sciences, Inc. Rhinovirus Infections Drug Product Introduction, Application and Specification
Table Theraclone Sciences, Inc. Rhinovirus Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Theraclone Sciences, Inc. Rhinovirus Infections Drug Production Growth Rate (2014-2019)
Table Theraclone Sciences, Inc. Rhinovirus Infections Drug Production Market Share (2014-2019)
Figure Theraclone Sciences, Inc. Rhinovirus Infections Drug Revenue Market Share (2014-2019)
Table Theraclone Sciences, Inc. Rhinovirus Infections Drug Main Business and Markets Served
Figure Global Rhinovirus Infections Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Rhinovirus Infections Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Rhinovirus Infections Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Rhinovirus Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Rhinovirus Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Rhinovirus Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Rhinovirus Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Rhinovirus Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Rhinovirus Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Rhinovirus Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Rhinovirus Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Rhinovirus Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Rhinovirus Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Rhinovirus Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Rhinovirus Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Rhinovirus Infections Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Rhinovirus Infections Drug by Application (2019-2025)
Table Rhinovirus Infections Drug Distributors List
Table Rhinovirus Infections Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AIMM Therapeutics B.V.、Biological Mimetics, Inc.、Biota Pharmaceuticals, Inc.、Boehringer Ingelheim GmbH、Johnson & Johnson、Novartis AG、Theraclone Sciences, Inc.、

★調査レポート[世界のライノウイルス感染薬市場 2019年] (コード：DATA909X14407)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のライノウイルス感染薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のインフルエンザAウイルス、H3N2サブタイプ感染薬市場 2019年
    DATA909X09790 / QYResearch / 2019年11月20日 / ※本調査レポートは、インフルエンザAウイルス、H3N2サブタイプ感染薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、NEO-8877、NP-025、NSC-61610、NVINF-1、その他に、用途別には、クリニック、病院、その他にセグメント区分し、インフルエンザAウイルス、H3N2サブタイプ感染薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・インフルエンザAウイルス、H3N2サブタイプ感染薬の世界市場概要 ・インフルエンザAウイルス、H3N2サブタイプ感染薬の製造コスト構成分析 ・インフルエンザAウイルス、H3N2サブタイプ感染薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・インフルエンザAウイルス、H3N2サブタイプ感染薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・インフルエンザAウイルス、H3N2サブタイプ感染薬のセグメント分析（種類別） （NEO-8877、NP-025、NSC-61610、NVINF-1、その他）...The global Influenza A Virus, H3N2 Subtype Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Influenza A Virus, H3N2 Subtype Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Influenza A Virus, H3N2 Subtype Infections Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Influenza A Virus, H3N2 Subtype Infections Drug in...
  • 世界のロタウイルス感染症治療薬市場 2019年
    DATA909X14590 / QYResearch / 2019年11月20日 / ※本調査レポートは、ロタウイルス感染症治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、農業、その他に、用途別には、クリニック、病院、その他にセグメント区分し、ロタウイルス感染症治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ロタウイルス感染症治療薬の世界市場概要 ・ロタウイルス感染症治療薬の製造コスト構成分析 ・ロタウイルス感染症治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ロタウイルス感染症治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ロタウイルス感染症治療薬のセグメント分析（種類別） （農業、その他）...The global Rotavirus Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rotavirus Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rotavirus Infections Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Rotavirus Infections Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の髄膜炎菌感染症治療薬市場 2019年
    DATA909X11920 / QYResearch / 2019年11月20日 / ※本調査レポートは、髄膜炎菌感染症治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、MGBBP-3、NCL-195、TP-10、その他に、用途別には、病院、クリニック、その他にセグメント区分し、髄膜炎菌感染症治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・髄膜炎菌感染症治療薬の世界市場概要 ・髄膜炎菌感染症治療薬の製造コスト構成分析 ・髄膜炎菌感染症治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・髄膜炎菌感染症治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・髄膜炎菌感染症治療薬のセグメント分析（種類別） （MGBBP-3、NCL-195、TP-10、その他）...The global Neisseria meningitidis Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Neisseria meningitidis Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neisseria meningitidis Infections Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Neisseria meningitidis Infections Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の人工関節感染症治療市場 2019年
    DATA909X13818 / QYResearch / 2019年11月20日 / ※本調査レポートは、人工関節感染症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他に、用途別には、病院、診療所、その他にセグメント区分し、人工関節感染症治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・人工関節感染症治療の世界市場概要 ・人工関節感染症治療の製造コスト構成分析 ・人工関節感染症治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・人工関節感染症治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・人工関節感染症治療のセグメント分析（種類別） （フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他）...The global Prosthetic Joint Infections Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Prosthetic Joint Infections Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prosthetic Joint Infections Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Prosthetic Joint Infections Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の淋菌感染症治療市場 2019年
    DATA909X11919 / QYResearch / 2019年11月20日 / ※本調査レポートは、淋菌感染症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン、その他に、用途別には、クリニック、病院、その他にセグメント区分し、淋菌感染症治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・淋菌感染症治療の世界市場概要 ・淋菌感染症治療の製造コスト構成分析 ・淋菌感染症治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・淋菌感染症治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・淋菌感染症治療のセグメント分析（種類別） （クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン、その他）...The global Neisseria Gonorrhoeae Infections Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Neisseria Gonorrhoeae Infections Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neisseria Gonorrhoeae Infections Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Neisseria Gonorrhoeae Infections Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の耐性緑膿菌感染症薬市場 2019年
    DATA909X14315 / QYResearch / 2019年11月20日 / ※本調査レポートは、耐性緑膿菌感染症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、半合成ペニシリン、セファロスポリン、ラクタム薬、その他に、用途別には、病院、診療所、在宅ケアにセグメント区分し、耐性緑膿菌感染症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・耐性緑膿菌感染症薬の世界市場概要 ・耐性緑膿菌感染症薬の製造コスト構成分析 ・耐性緑膿菌感染症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・耐性緑膿菌感染症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・耐性緑膿菌感染症薬のセグメント分析（種類別） （半合成ペニシリン、セファロスポリン、ラクタム薬、その他）...The global Resistant Pseudomonas Aeruginosa Infections Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Resistant Pseudomonas Aeruginosa Infections Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Resistant Pseudomonas Aeruginosa Infections Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Resistant Pseudomonas Aeruginosa Infections Drugs in North America, Europe, China, Japan, Southeast Asia and...
  • 後天性感染検査の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101983 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、後天性感染検査の世界市場について調べ、まとめました。種類別セグメントは、疾病検査、薬剤耐性検査等、用途別セグメントは、病院、診療所、外来手術センター（ASC）、その他等に区分しました。後天性感染検査の世界市場概観、企業動向、企業別後天性感染検査シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・後天性感染検査の市場概観 ・後天性感染検査の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・後天性感染検査の企業別販売動向、市場シェア、市場集中度、競争動向 ・後天性感染検査の世界市場規模 ・後天性感染検査の北米市場分析（アメリカ、カナダ、メキシコ等） ・後天性感染検査のアメリカ市場規模推移 ・後天性感染検査のカナダ市場規模推移 ・後天性感染検査のメキシコ市場規模推移 ・後天性感染検査のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Hospital-acquired infections are the infections caused by bacterial, viral, and fungal pathogens. These infections can be acquired in clinical settings, such as nursing home, rehabilitation facility, outpatient clinic, or other clinical settings. Scope of the Report: The global Acquired Infections Testing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United...
  • 真菌感染症診断の世界市場：規模・現状・予測2019-2025
    DATA909X18496 / QYResearch / 2019年11月25日 / ※当調査レポートでは、真菌感染症診断の世界市場について調査・分析し、真菌感染症診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（臨床検査、生検、医療画像）、用途別（病院、研究所、診断センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の真菌感染症診断市場動向 ・主要企業別マーケットシェア ・真菌感染症診断の種類別市場規模2014-2019 （臨床検査、生検、医療画像） ・真菌感染症診断の用途別市場規模2014-2019 （病院、研究所、診断センター、その他） ・真菌感染症診断の北米市場：主要企業・種類別/用途別市場規模 ・真菌感染症診断のヨーロッパ市場：主要企業・種類別/用途別市場規模...There are more than 300 species of fungi that are pathogenic to humans. In addition to cryptococcus neoformans and fungi, the medically significant pathogenic fungi are almost all moldsIn 2018, the global Fungal Infections Diagnosis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Fungal Infections Diagnosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Fungal Infections Diagnosis development in North America, Europe and Asia-Pacific. The key...

    • ◆H&Iグローバルリサーチのお客様（例）◆